Lentiviral vectors can be used for full-length dystrophin gene therapy. (2017)

First Author: Counsell JR
Attributed to:  The MRC Confidence in Concepts at UCL Fund 2014 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-00152-5

PubMed Identifier: 28250438

Publication URI: http://europepmc.org/abstract/MED/28250438

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322